You just read:

Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA

News provided by

Takeda Pharmaceutical Company Limited

Jul 30, 2015, 10:21 ET